|
1
|
Dorfman HD and Czerniak B: Bone cancers.
Cancer 75 (1 Suppl). S203–S210. 1995. View Article : Google Scholar
|
|
2
|
Whelan JS and Davis LE: Osteosarcoma,
chondrosarcoma, and chordoma. J Clin Oncol. 36:188–193. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Angelini A, Guerra G, Mavrogenis AF, Pala
E, Picci P and Ruggieri P: Clinical outcome of central conventional
chondrosarcoma. J Surg Oncol. 106:929–937. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Galoyan A: Neurochemistry of brain
neuroendocrine immune system: Signal molecules. Neurochem Res.
25:1343–1355. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Galoian K, Temple TH and Galoyan A:
Cytostatic effect of the hypothalamic cytokine PRP-1 is mediated by
mTOR and cMyc inhibition in high grade chondrosarcoma. Neurochem
Res. 36:812–818. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Galoian KA, Guettouche T, Issac B, Qureshi
A and Temple HT: Regulation of onco and tumor suppressor MiRNAs by
mTORC1 inhibitor PRP-1 in human chondrosarcoma. Tumour Biol.
35:2335–2341. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Galoian K, Qureshi A, Wideroff G and
Temple HT: Restoration of desmosomal junction protein expression
and inhibition of H3K9-specific histone demethylase activity by
cytostatic proline-rich polypeptide-1 leads to suppression of
tumorigenic potential in human chondrosarcoma cells. Mol Clin
Oncol. 3:171–178. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Galoian K, Qureshi A, D'Ippolito G,
Schiller PC, Molinari M, Johnstone AL, Brothers SP, Paz AC and
Temple HT: Epigenetic regulation of embryonic stem cell marker
miR302C in human chondrosarcoma as determinant of antiproliferative
activity of proline-rich polypeptide 1. Int J Oncol. 47:465–472.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Galoian K, Abrahamyan S, Chailyan G,
Qureshi A, Patel P, Metser G, Moran A, Sahakyan I, Tumasyan N, Lee
A, et al: Toll like receptors TLR1/2, TLR6 and MUC5B as binding
interaction partners with cytostatic proline rich polypeptide 1 in
human chondrosarcoma. Int J Oncol. 52:139–154. 2018.PubMed/NCBI
|
|
10
|
Lohberger B, Rinner B, Stuendl N, Absenger
M, Liegl-Atzwanger B, Walzer SM, Windhager R and Leithner A:
Aldehyde dehydrogenase 1, a potential marker for cancer stem cells
in human sarcoma. PLoS One. 7:e436642012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Greco N, Schott T, Mu X, Rothenberg A,
Voigt C, McGough RL III, Goodman M, Huard J and Weiss KR: ALDH
activity correlates with metastatic potential in primary sarcomas
of bone. J Cancer Ther. 5:331–338. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Clevers H: Wnt/beta-catenin signaling in
development and disease. Cell. 127:469–480. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kageshita T, Hamby CV, Ishihara T,
Matsumoto K, Saida T and Ono T: Loss of beta-catenin expression
associated with disease progression in malignant melanoma. Br J
Dermatol. 145:210–216. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Maelandsmo GM, Holm R, Nesland JM, Fodstad
Ø and Flørenes VA: Reduced beta-catenin expression in the cytoplasm
of advanced-stage superficial spreading malignant melanoma. Clin
Cancer Res. 9:3383–3388. 2003.PubMed/NCBI
|
|
15
|
Chen C, Zhao M, Tian A, Zhang X, Yao Z and
Ma X: Aberrant activation of Wnt/β-catenin signaling drives
proliferation of bone sarcoma cells. Oncotarget. 6:17570–17583.
2015.PubMed/NCBI
|
|
16
|
Yi XJ, Zhao YH, Qiao LX, Jin CL, Tian J
and Li QS: Aberrant Wnt/β-catenin signaling and elevated expression
of stem cell proteins are associated with osteosarcoma side
population cells of high tumorigenicity. Mol Med Rep. 12:5042–5048.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Basu-Roy U, Seo E, Ramanathapuram L, Rapp
TB, Perry JA, Orkin SH, Mansukhani A and Basilico C: Sox2 maintains
self renewal of tumor-initiating cells in osteosarcomas. Oncogene.
31:2270–2282. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Matushansky I, Hernando E, Socci ND, Mills
JE, Matos TA, Edgar MA, Singer S, Maki RG and Cordon-Cardo C:
Derivation of sarcomas from mesenchymal stem cells via inactivation
of the Wnt pathway. J Clin Invest. 117:3248–3257. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cojoc M, Peitzsch C, Kurth I, Trautmann F,
Kunz-Schughart LA, Telegeev GD, Stakhovsky EA, Walker JR, Simin K,
Lyle S, et al: Aldehyde dehydrogenase is regulated by β-catenin/TCF
and promotes radioresistance in prostate cancer progenitor cells.
Cancer Res. 75:1482–1494. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim JY, Lee HY, Park KK, Choi YK, Nam JS
and Hong IS: CWP232228 targets liver cancer stem cells through
Wnt/β-catenin signaling: A novel therapeutic approach for liver
cancer treatment. Oncotarget. 7:20395–20409. 2016.PubMed/NCBI
|
|
21
|
Shan S, Lv Q, Zhao Y, Liu C, Sun Y, Xi K,
Xiao J and Li C: Wnt/β-catenin pathway is required for epithelial
to mesenchymal transition in CXCL12 over expressed breast cancer
cells. Int J Clin Exp Pathol. 8:12357–12367. 2015.PubMed/NCBI
|
|
22
|
Di Fiore R, Fanale D, Drago-Ferrante R,
Chiaradonna F, Giuliano M, De Blasio A, Amodeo V, Corsini LR, Bazan
V, Tesoriere G, et al: Genetic and molecular characterization of
the human osteosarcoma 3AΒ-OS cancer stem cell line: A possible
model for studying osteosarcoma origin and stemness. J Cell
Physiol. 228:1189–1201. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
He C, Gao H, Fan X, Wang M, Liu W, Huang W
and Yang Y: Identification of a novel miRNA-target gene regulatory
network in osteosarcoma by integrating transcriptome analysis. Int
J Clin Exp Pathol. 8:8348–8357. 2015.PubMed/NCBI
|
|
24
|
Di Fiore R, Drago-Ferrante R, Pentimalli
F, Di Marzo D, Forte IM, D'Anneo A, Carlisi D, De Blasio A,
Giuliano M, Tesoriere G, et al: MicroRNA-29β-1 impairs in vitro
cell proliferation, self-renewal and chemoresistance of human
osteosarcoma 3AB-OS cancer stem cells. Int J Oncol. 45:2013–2023.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Di Fiore R, Drago-Ferrante R, Pentimalli
F, Di Marzo D, Forte IM, Carlisi D, De Blasio A, Tesoriere G,
Giordano A and Vento R: Let-7d miRNA shows both antioncogenic and
oncogenic functions in osteosarcoma-derived 3AB-OS cancer stem
cells. J Cell Physiol. 231:1832–1841. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kanamori M, Sano A, Yasuda T, Hori T and
Suzuki K: Array-based comparative genomic hybridization for
genomic-wide screening of DNA copy number alterations in aggressive
bone tumors. J Exp Clin Cancer Res. 31:1002012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang W, Wen Q, Luo J, Chu S, Chen L, Xu L,
Zang H, Alnemah MM, Li J, Zhou J and Fan S: Suppression of
β-catenin nuclear translocation by CGP57380 decelerates poor
progression and potentiates radiation-induced apoptosis in
nasopharyngeal carcinoma. Theranostics. 7:2134–2149. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bell JB, Eckerdt F, Dhruv HD, Finlay D,
Peng S, Kim S, Kroczynska B, Beauchamp EM, Alley K, Clymer J, et
al: Differential response of glioma stem cells to arsenic trioxide
therapy is regulated by MNK1 and mRNA translation. Mol Cancer Res.
16:32–46. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yang L, Ren Y, Yu X, Qian F, Bian BS, Xiao
HL, Wang WG, Xu SL, Yang J, Cui W, et al: ALDH1A1 defines invasive
cancer stem-like cells and predicts poor prognosis in patients with
esophageal squamous cell carcinoma. Mod Pathol. 27:775–783. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Arango NA, Szotek PP, Manganaro TF, Oliva
E, Donahoe PK and Teixeira J: Conditional deletion of beta-catenin
in the mesenchyme of the developing mouse uterus results in a
switch to adipogenesis in the myometrium. Dev Biol. 288:276–283.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gregory CA, Gunn WG, Reyes E, Smolarz AJ,
Munoz J, Spees JL and Prockop DJ: How Wnt signaling affects bone
repair by mesenchymal stem cells from the bone marrow. Ann N Y Acad
Sci. 1049:97–106. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lee N, Smolarz AJ, Olson S, David O,
Reiser J, Kutner R, Daw NC, Prockop DJ, Horwitz EM and Gregory CA:
A potential role for Dkk-1 in the pathogenesis of osteosarcoma
predicts novel diagnostic and treatment strategies. Br J Cancer.
97:1552–1559. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kirikoshi H and Katoh M: Expression of
WRCH1 in human cancer and down-regulation of WRCH1 by
beta-estradiol in MCF-7 cells. Int J Oncol. 20:777–783.
2002.PubMed/NCBI
|
|
34
|
Vallejo A, Perurena N, Guruceaga E, Mazur
PK, Martinez-Canarias S, Zandueta C, Valencia K, Arricibita A,
Gwinn D, Sayles LC, et al: An integrative approach unveils FOSL1 as
an oncogene vulnerability in KRAS-driven lung and pancreatic
cancer. Nat Commun. 8:142942017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Schiavone D, Dewilde S, Vallania F,
Turkson J, Di Cunto F and Poli V: The RhoU/Wrch1 Rho GTPase gene is
a common transcriptional target of both the gp130/STAT3 and Wnt-1
pathways. Biochem J. 421:283–292. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mani M, Carrasco DE, Zhang Y, Takada K,
Gatt ME, Dutta-Simmons J, Ikeda H, Diaz-Griffero F, Pena-Cruz V,
Bertagnolli M, et al: BCL9 promotes tumor progression by conferring
enhanced proliferative, metastatic, and angiogenic properties to
cancer cells. Cancer Res. 69:7577–7586. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ewen ME, Sluss HK, Sherr CJ, Matsushime H,
Kato J and Livingston DM: Functional interactions of the
retinoblastoma protein with mammalian D-type cyclins. Cell.
73:487–497. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Guan PP, Yu X, Guo JJ, Wang Y, Wang T, Li
JY, Konstantopoulos K, Wang ZY and Wang P: By activating matrix
metalloproteinase-7, shear stress promotes chondrosarcoma cell
motility, invasion and lung colonization. Oncotarget. 6:9140–9159.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jovanovic V, Dugast AS, Heslan JM,
Ashton-Chess J, Giral M, Degauque N, Moreau A, Pallier A,
Chiffoleau E, Lair D, et al: Implication of matrix
metalloproteinase 7 and the noncanonical wingless-type signaling
pathway in a model of kidney allograft tolerance induced by the
administration of anti-donor class II antibodies. J Immunol.
180:1317–1325. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lien WH and Fuchs E: Wnt some lose some:
Transcriptional governance of stem cells by Wnt/β-catenin
signaling. Genes Dev. 28:1517–1532. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Valenta T, Hausmann G and Basler K: The
many faces and functions of β-catenin. EMBO J. 31:2714–2736. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Anastas JN and Moon RT: WNT signalling
pathways as therapeutic targets in cancer. Nat Rev Cancer.
13:11–26. 2013. View Article : Google Scholar : PubMed/NCBI
|
